# Evidencing the role of a conserved polar signaling channel in the activation mechanism of the μ-opioid receptor

**Authors:** Arijit Sarkar, Szabolcs Dvorácskó, Zoltán Lipinszki, Argha Mitra, Mária Harmati, Krisztina Buzás, Attila Borics

PMC · DOI: 10.1016/j.csbj.2025.07.014 · Computational and Structural Biotechnology Journal · 2025-07-16

## TL;DR

The study shows that a conserved polar channel in the μ-opioid receptor is crucial for transmitting activation signals and connecting ligand binding to receptor function.

## Contribution

The study provides evidence for a conserved polar signaling channel's role in opioid receptor activation through mutations and simulations.

## Key findings

- Mutating polar channel residues disrupts agonist binding and Gi protein stimulation.
- The polar channel shows correlated motions in active states of class A receptors.
- Allosteric connection between the ligand binding pocket and intracellular surface is confirmed.

## Abstract

The activity of G protein-coupled receptors has been generally linked to dynamically interconverting structural and functional states and the process of activation was proposed to be controlled by an interconnecting network of conformational switches in the transmembrane domain. However, it is yet to be uncovered how ligands with different extent of functional effect exert their actions. According to our recent hypothesis, the transmission of the external stimulus is accompanied by the shift of macroscopic polarization in the transmembrane domain, furnished by concerted movements of conserved polar amino acids and the rearrangement of polar species. Previously, we have examined the μ-opioid, β2-adrenergic and type 1 cannabinoid receptors by performing molecular dynamics simulations. Results revealed correlated dynamics of a polar signaling channel connecting the orthosteric binding pocket and the intracellular G protein-binding surface in all three class A receptors. In the present study, the interplay of this polar signaling channel in the activation mechanism was evidenced by systematic mutation of the channel residues of the μ-opioid receptor. Mutant receptors were analyzed utilizing molecular dynamics simulations and characterized in vitro by means of radioligand receptor binding and G protein stimulation assays. Apart from one exception, all mutants failed to bind the endogenous agonist endomorphin-2 and to stimulate the Gi protein complex. Furthermore, mutation results confirmed allosteric connection between the binding pocket and the intracellular surface. The strong association and optimal bioactive orientation of the bound agonist was found to be crucial for the initiation of correlated motions and consequent signaling.

•A conserved polar channel in the transmembrane domain conveys activation signal.•Channel constituents perform concerted motions in active signaling states.•Altering polarity of channel constituents affects ligand binding.•Altering polarity of channel constituents affects receptor function.•Strong allosteric connection between ligand binding pocket and intracellular surface.

A conserved polar channel in the transmembrane domain conveys activation signal.

Channel constituents perform concerted motions in active signaling states.

Altering polarity of channel constituents affects ligand binding.

Altering polarity of channel constituents affects receptor function.

Strong allosteric connection between ligand binding pocket and intracellular surface.

## Linked entities

- **Chemicals:** endomorphin-2 (PubChem CID 5311081)

## Full-text entities

- **Genes:** Oprm1 (opioid receptor, mu 1) [NCBI Gene 18390] {aka M-OR-1, MOP-R, MOR-1, MOR-1O, Oprm, mor}, GNAI1 (G protein subunit alpha i1) [NCBI Gene 2770] {aka Gi, HG1B, NEDHISB}, OPRM1 (opioid receptor mu 1) [NCBI Gene 4988] {aka LMOR, M-OR-1, MOP, MOR, MOR1, OPRM}
- **Diseases:** Cancer (MESH:D009369)
- **Chemicals:** GTP (MESH:D006160), Na+ (MESH:D012964), MgCl2 (MESH:D015636), naloxone (MESH:D009270), tetracycline (MESH:D013752), cAMP (MESH:D000242), cholesterol (MESH:D002784), glucose (MESH:D005947), EDTA (MESH:D004492), NaCl (MESH:D012965), DMEM (-), glutamine (MESH:D005973), HCl (MESH:D006851), EM2 (MESH:C105294), Hygromycin B (MESH:D006921), DPBS (MESH:C012939), lipid (MESH:D008055), hydrogen (MESH:D006859), palmitoyl-sphingomyelin (MESH:C033171), EGTA (MESH:D004533), G418 sulfate (MESH:C010680), Cl- (MESH:D002713), water (MESH:D014867), N-acetylneuraminic acid (MESH:D019158), POPC (MESH:C065191), POPE (MESH:C057561), GDP (MESH:D006153), amino acid (MESH:D000596), CO2 (MESH:D002245), GTPgammaS (MESH:D016244), doxycycline (MESH:D004318)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** Y326F, D340L, D340N, N328D, N328L, Y328
- **Cell lines:** CHO-MOP — Mus musculus (Mouse), Transformed cell line (CVCL_9T81), CHO-K1 — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_0214)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12309854/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12309854/full.md

## References

70 references — full list in the complete paper: https://tomesphere.com/paper/PMC12309854/full.md

---
Source: https://tomesphere.com/paper/PMC12309854